Advertisement

Prophylactic Regimens in the Intensive Care Unit

  • Alexander E. Swift
  • Walter A. Wynkoop
  • Gilbert E. D’Alonzo
Chapter

Abstract

Identify risk factors associated with the development of deep vein thrombosis and its consequence, pulmonary embolism. Understand the indications and contraindications for medical, mechanical, and inferior vena cava filter prophylaxis, and describe the available methods for each. Identify the major physiologic mechanism associated with stress-induced gastritis and ulceration, and identify the risk factors associated with this condition. Know the methods used for prophylaxis of stress-induced gastritis and ulceration and the potential complications of the medical therapies used for this condition. Identify the nosocomial infections common in the intensive care unit and the causative organisms responsible. Discuss the various risk factors associated with the development of iatrogenic or preventable infection in critically ill patients. Employ a variety of effective prophylactic regimens to nosocomial infection in the intensive care unit: healthcare/ventilator associated pneumonia (VAP), catheter-related bloodstream infection, and genitourinary tract infection in critically ill patients.

Keywords

Deep Vein Thrombosis Deep Venous Thrombosis Nosocomial Pneumonia Complicated Urinary Tract Infection Danaparoid Sodium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:381S-453S.PubMedCrossRefGoogle Scholar
  2. 2.
    Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-1606.PubMedCrossRefGoogle Scholar
  3. 3.
    Wood KE. Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121:877-905.PubMedCrossRefGoogle Scholar
  4. 4.
    Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335(10):701-707.PubMedCrossRefGoogle Scholar
  5. 5.
    Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of Randomized Controlled Trials. Arch Intern Med. 2007;167:1476-1486.PubMedCrossRefGoogle Scholar
  6. 6.
    Martel N, Lee J, Wells PS. Risk for heparin-induced thrombo­cytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106:2710-2715.PubMedCrossRefGoogle Scholar
  7. 7.
    Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.PubMedCrossRefGoogle Scholar
  8. 8.
    Warkentin TE, Cook RJ, Marder VJ, et al. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood. 2005;106:3791.PubMedCrossRefGoogle Scholar
  9. 9.
    Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793-800.PubMedCrossRefGoogle Scholar
  10. 10.
    Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305-1310.PubMedCrossRefGoogle Scholar
  11. 11.
    Killewich LA, Cahan MA, Hanna DJ, et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg. 2002;36:953-958.PubMedCrossRefGoogle Scholar
  12. 12.
    Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM; Miami Deep Vein Thrombosis Study Group. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg. 2003;90:1338-1344.PubMedCrossRefGoogle Scholar
  13. 13.
    Linsenmaier U, Rieger J, Schenk F, Rock C, Mangel E, Pfeifer KJ. Indications, management, and complications of temporary inferior vena cava filters. Cardiovasc Intervent Radiol. 1998;21:464-469.PubMedCrossRefGoogle Scholar
  14. 14.
    Hoff WS, Hoey BA, Wainwright GA, et al. Early experience with retrievable inferior vena cava filters in high-risk trauma patients. J Am Coll Surg. 2004;199:869-874.PubMedCrossRefGoogle Scholar
  15. 15.
    Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med. 1994;121:568-575.PubMedGoogle Scholar
  16. 16.
    Cook DJ, Fuller MB, Guyatt GH. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330:377-381.PubMedCrossRefGoogle Scholar
  17. 17.
    ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56:347.Google Scholar
  18. 18.
    Cook DJ, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998;338:791-797.PubMedCrossRefGoogle Scholar
  19. 19.
    Cook DJ, Reeve BK, Guyatt GH. Stress ulcer prophylaxis in critically ill patients. JAMA. 1996;275:308-314.PubMedCrossRefGoogle Scholar
  20. 20.
    Maier RV, Mitchell D, Gentilello L. Optimal therapy for stress gastritis. Ann Surg. 1994;220:353-360.PubMedCrossRefGoogle Scholar
  21. 21.
    Driks MR, Craven DE, Celli BR. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type-2 blockers. N Engl J Med. 1987;317:1376-1382.PubMedCrossRefGoogle Scholar
  22. 22.
    Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med. 2004;32:2008-2013.PubMedCrossRefGoogle Scholar
  23. 23.
    Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33:760-765.PubMedCrossRefGoogle Scholar
  24. 24.
    Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepato­gastroenterology. 2004;51:757-761.PubMedGoogle Scholar
  25. 25.
    Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA. 1995;274:639-644.PubMedCrossRefGoogle Scholar
  26. 26.
    Estes RJ, Meduri GU. The pathogenesis of ventilator-associated pneumonia: mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med. 1995;21:365-383.PubMedCrossRefGoogle Scholar
  27. 27.
    Fourrier F, Dubois D, Pronnier P, et al. Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-­controlled multicenter study. Crit Care Med. 2005;33:1728-1735.PubMedCrossRefGoogle Scholar
  28. 28.
    Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2006;173(12):1348-1355.PubMedCrossRefGoogle Scholar
  29. 29.
    Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 1991;338:859-862.PubMedCrossRefGoogle Scholar
  30. 30.
    Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med. 1992;326:594-599.PubMedCrossRefGoogle Scholar
  31. 31.
    Hammond J, Potgieter P, Saunders GL, Forder A. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet. 1992;340:5-9.PubMedCrossRefGoogle Scholar
  32. 32.
    Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia: a randomized, placebo-controlled, double-blind clinical trial. JAMA. 1991;265:2704-2710.PubMedCrossRefGoogle Scholar
  33. 33.
    de Smet AMGA, Kluytmans JA, Cooper BS, et al. Decontami­nation of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20-31.PubMedCrossRefGoogle Scholar
  34. 34.
    Cook D, De Jonghe B, Brochard L, Brun-Buisson C. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA. 1998;279:781-787.PubMedCrossRefGoogle Scholar
  35. 35.
    Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL. Care of the ventilator circuit and its relation to ventilator associated pneumonia. Respir Care. 2003;48:869-879.PubMedGoogle Scholar
  36. 36.
    Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34:2766-2772.PubMedCrossRefGoogle Scholar
  37. 37.
    Adair CG, Gorman SP, Byers LM, et al. Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med. 2002;28:426-431.PubMedCrossRefGoogle Scholar
  38. 38.
    Kollef MH, Afessa B, Anzueto A, et al. NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805-813.PubMedCrossRefGoogle Scholar
  39. 39.
    Smulders K, van der Hoeven H, Weers-Pothoff I, Vandenbroucke-Grauls C. A Randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest. 2002;121:858-862.PubMedCrossRefGoogle Scholar
  40. 40.
    Lorente L, Lecuona M, Jimenez A, Mora ML, Sierra A. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med. 2007;176:1079-1083.PubMedCrossRefGoogle Scholar
  41. 41.
    Young PJ, Pakeerathan S, Blunt MC, Subramanya S. A low-volume, low-pressure tracheal tube cuff reduces pulmonary aspiration. Crit Care Med. 2006;34:632-639.PubMedCrossRefGoogle Scholar
  42. 42.
    Valencia M, Ferrer M, Farre R, et al. Automatic control of tracheal tube cuff pressure in ventilated patients in semirecumbent position: a randomized trial. Crit Care Med. 2007;35:1543-1549.PubMedCrossRefGoogle Scholar
  43. 43.
    O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2002;35:1281-1307.CrossRefGoogle Scholar
  44. 44.
    Mermel L, Farr B, Sherertz R, et al. Guidelines for the management of intravascular catheter–related infections. Clin Infect Dis. 2001;32:1249-1272.PubMedCrossRefGoogle Scholar
  45. 45.
    Bouza E, Alvarado N, Alcalá L, Pérez MJ, Rincón C, Muñoz P. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis. 2007;44:820-826.PubMedCrossRefGoogle Scholar
  46. 46.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med. 2006;34:905-907.CrossRefGoogle Scholar
  47. 47.
    Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter related bloodstream infection by use of an antiseptic impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127:257-266.PubMedGoogle Scholar
  48. 48.
    Pronovost P, Needham D, Berenholtz S, et al. An Intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-2732.PubMedCrossRefGoogle Scholar
  49. 49.
    Maki DG, Mermel LA, Klugar D, et al. The efficacy of a chlorhexidine impregnated sponge (Biopatch) for the prevention of intravascularcatheter-related infection- a prospective randomized controlled multicenter study [abstract 143C]. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada. American Society for Microbiology, 2000.Google Scholar
  50. 50.
    Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA. 1987;258:2396-2403.PubMedCrossRefGoogle Scholar
  51. 51.
    Eyer S, Brummit C, Crossley K, Siegel R, Cerra F. Catheter related sepsis: prospective, randomized study of three methods of long term catheter maintenance. Crit Care Med. 1990;18:1073-1079.PubMedCrossRefGoogle Scholar
  52. 52.
    Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med. 1997;25:1417-1424.PubMedCrossRefGoogle Scholar
  53. 53.
    Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA. 1987;258:1777-1781.PubMedCrossRefGoogle Scholar
  54. 54.
    Paradisi F, Giampaolo C, Mangani V. Urosepsis in the critical care unit. Crit Care Clin. 1998;14:165-180.PubMedCrossRefGoogle Scholar
  55. 55.
    Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med. 2000;160:673-677.PubMedCrossRefGoogle Scholar
  56. 56.
    Stephan F, Sax H, Wachsmuth M, Hoffmeyer P, Clergue F, Pittet D. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study. Clin Infect Dis. 2006;42:1544-1551.PubMedCrossRefGoogle Scholar
  57. 57.
    Jain P, Parada JP, David A, Smith LG. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995;155:1425-1429.PubMedCrossRefGoogle Scholar
  58. 58.
    Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000;30:14-18.PubMedCrossRefGoogle Scholar

Additional Reading

  1. DVT ProphylaxisGoogle Scholar
  2. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:381S-453S.PubMedCrossRefGoogle Scholar
  3. Stress GastritisGoogle Scholar
  4. Miller TA, Tornwall MS, Moody FG. Stress erosive gastritis. In: Wells SA, ed. Current Problems in Surgery. St. Louis, MO: Mosby Year Book; 1991.Google Scholar
  5. Binder HJ. Selective summaries: stress erosive gastritis: what is optimal therapy and who should undergo it? Gastroenterology. 1995;109:626-632.CrossRefGoogle Scholar
  6. Cook DJ, Reeve BK, Guyatt GH. Stress ulcer prophylaxis in critically ill patients. JAMA. 1996;275:308-314.PubMedCrossRefGoogle Scholar
  7. Cook DJ, Laine LA, Guyatt GH, et al. Nosocomial pneumonia and the role of gastric pH. Chest. 1991;100:7-13.PubMedCrossRefGoogle Scholar
  8. Martin LF, Booth FV, Reines HD, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332-337.PubMedCrossRefGoogle Scholar
  9. O’Keefe GE, Gentilb LM, Maier RV. Incidence of infectious complications associated with the use of H2-receptor antagonists in critically ill trauma patients. Ann Surg. 1998;227:120-125.PubMedCrossRefGoogle Scholar
  10. Heyland DK, Cook DJ, Jaeschke R, et al. Selective decontamina­tion of the digestive tract. An overview. Chest. 1994;105:1221-1229.PubMedCrossRefGoogle Scholar
  11. Maier RV, Mitchell D, Gentiello L. Optimal therapy for stress gastritis. Ann Surg. 1994;220:353-363.PubMedCrossRefGoogle Scholar
  12. Martin LF, Booth FV, Reines HD, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332-337.PubMedCrossRefGoogle Scholar
  13. Nosocomial InfectionGoogle Scholar
  14. Lode HM, Schaberg T, Raffenberg M, et al. Nosocomial pneumonia in the critical care unit. Crit Care Clin. 1998;14:119-133.PubMedCrossRefGoogle Scholar
  15. Meduri GU, Johanson WG, editors. International consensus conference: clinical investigation of ventilator-associated pneumonia. Chest. 1992;102 (suppl 1):551S-588S.Google Scholar
  16. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106:221-235.PubMedCrossRefGoogle Scholar
  17. Yokoe DS et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:S12-S21.PubMedCrossRefGoogle Scholar
  18. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993;6:428-442.PubMedGoogle Scholar
  19. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Ctrl. 1988;16:128-140.CrossRefGoogle Scholar
  20. Haley RW, Culvar DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121:182-205.PubMedGoogle Scholar
  21. Fiddian-Green RG, Baker S. Nosocomial pneumonia in the critically ill: product of aspiration or translocation? Crit Care Med. 1991;19:763-769.PubMedGoogle Scholar
  22. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med. 1999;340:627-634.PubMedCrossRefGoogle Scholar
  23. Heyland D, Mandell LA. Gastric colonization by gram-negative bacilli and nosocomial pneumonia in the intensive care unit patient: evidence for causation. Chest. 1992;101:187-193.PubMedCrossRefGoogle Scholar
  24. Norwood S, Ruby A, Civetta J, Cortes V. Catheter-related infections and associated septicemia. Chest. 1991;99:968-975.PubMedCrossRefGoogle Scholar
  25. Amin M. Antibacterial prophylaxis in urology: a review. Am J Med. 1992;92 (suppl 4A):114-117.CrossRefGoogle Scholar
  26. Cunnin CM. Detection, Prevention and Management of Urinary Tract Infections. 4th ed. Philadelphia: Lea & Febiger; 1987.Google Scholar
  27. Sobel JD. Pathogenesis of urinary tract infections: host defenses. Infect Dis Clin N Am. 1987;1:751-772.Google Scholar
  28. Tambyah P, Halverson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74:131-136.PubMedCrossRefGoogle Scholar
  29. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin N Am. 1987;1:823-854.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Alexander E. Swift
    • 1
  • Walter A. Wynkoop
    • 2
  • Gilbert E. D’Alonzo
    • 3
  1. 1.Department of Pulmonary and Critical Care MedicineTemple University HospitalPhiladelphiaUSA
  2. 2.BrickUSA
  3. 3.Pulmonary and Critical Care MedicineTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations